Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · Real-Time Price · USD

3.075

-0.245 (-7.38%)

At close: Sep 25, 2026, 4:00 PM EDT

3.030

-0.045 (-1.46%)

Pre-market: Sep 28, 2026, 4:39 AM EDT

Larimar Therapeutics Employees

Larimar Therapeutics had 71 employees as of December 31, 2025. The number of employees increased by 6 or 9.23% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

9.23%

Revenue / Employee

n/a

Profits / Employee

-$2,431,056

Market Cap

320.98M

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	71	6	9.23%
Dec 31, 2024	65	23	54.76%
Dec 31, 2023	42	16	61.54%
Dec 31, 2022	26	-5	-16.13%
Dec 31, 2021	31	3	10.71%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Cabaletta Bio	158
Enanta Pharmaceuticals	120
Ocugen	116
Artiva Biotherapeutics	115
C4 Therapeutics	104
BridgeBio Oncology Therapeutics	88
Orchestra BioMed Holdings	86
Fennec Pharmaceuticals	35